Literature DB >> 24705967

Development and validation of a risk factor scoring system for first-trimester prediction of preeclampsia.

Katherine R Goetzinger1, Methodius G Tuuli1, Alison G Cahill1, George A Macones1, Anthony O Odibo1.   

Abstract

OBJECTIVE: The aim of this study was to develop a multiparameter risk-based scoring system for first-trimester prediction of preeclampsia and to validate this scoring system in our patient population. STUDY
DESIGN: Secondary analysis of a prospective cohort of 1,200 patients presenting for first-trimester aneuploidy screening. Maternal serum pregnancy-associated plasma protein A (PAPP-A) levels were measured and bilateral uterine artery (UA) Doppler studies performed. Using the first half of the study population, a prediction model for preeclampsia was created. Test performance characteristics were used to determine the optimal score for predicting preeclampsia. This model was then validated in the second half of the population.
RESULTS: Significant risk factors and their weighted scores derived from the prediction model were chronic hypertension (4), history of preeclampsia (3), pregestational diabetes (2), body mass index ≥ 30 kg/m(2) (2), bilateral UA notching (1), and PAPP-A MoM < 10 th percentile (1). The area under the curve (AUC) for the risk scoring system was 0.76 (95% confidence interval [CI], 0.69-0.83), and the optimal threshold for predicting preeclampsia was a total score of ≥ 6. This AUC did not differ significantly from the AUC observed in our validation cohort (AUC, 0.78 [95% CI, 0.69-0.86]; p = 0.75].
CONCLUSION: Our proposed risk factor scoring system demonstrates modest accuracy but excellent reproducibility for first-trimester prediction of preeclampsia. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24705967      PMCID: PMC4185255          DOI: 10.1055/s-0034-1371705

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  19 in total

1.  First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications.

Authors:  C Y Ong; A W Liao; K Spencer; S Munim; K H Nicolaides
Journal:  BJOG       Date:  2000-10       Impact factor: 6.531

2.  First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia.

Authors:  K Melchiorre; B Wormald; K Leslie; A Bhide; B Thilaganathan
Journal:  Ultrasound Obstet Gynecol       Date:  2008-08       Impact factor: 7.299

3.  Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia.

Authors:  Jennie Laigaard; Tina Sørensen; Sophie Placing; Peter Holck; Camilla Fröhlich; Karen R Wøjdemann; Karin Sundberg; Anne-Cathrine Shalmi; Ann Tabor; Bent Nørgaard-Pedersen; Bent Ottesen; Michael Christiansen; Ulla M Wewer
Journal:  Obstet Gynecol       Date:  2005-07       Impact factor: 7.661

4.  Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population.

Authors:  O Gómez; J M Martínez; F Figueras; M Del Río; V Borobio; B Puerto; O Coll; V Cararach; J A Vanrell
Journal:  Ultrasound Obstet Gynecol       Date:  2005-10       Impact factor: 7.299

5.  First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).

Authors:  Lorraine Dugoff; John C Hobbins; Fergal D Malone; T Flint Porter; David Luthy; Christine H Comstock; Gary Hankins; Richard L Berkowitz; Irwin Merkatz; Sabrina D Craigo; Ilan E Timor-Tritsch; Steven R Carr; Honor M Wolfe; John Vidaver; Mary E D'Alton
Journal:  Am J Obstet Gynecol       Date:  2004-10       Impact factor: 8.661

6.  Bilateral notching of uterine arteries at 12--14 weeks of gestation for prediction of hypertensive disorders of pregnancy.

Authors:  Merja Vainio; Erkki Kujansuu; Anna-Maija Koivisto; Johanna Mäenpää
Journal:  Acta Obstet Gynecol Scand       Date:  2005-11       Impact factor: 3.636

7.  Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.

Authors:  R Akolekar; E Zaragoza; L C Y Poon; S Pepes; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2008-11       Impact factor: 7.299

8.  Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia.

Authors:  W Plasencia; N Maiz; S Bonino; C Kaihura; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2007-10       Impact factor: 7.299

9.  Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia.

Authors:  Katherine R Goetzinger; Yan Zhong; Alison G Cahill; Linda Odibo; George A Macones; Anthony O Odibo
Journal:  J Ultrasound Med       Date:  2013-09       Impact factor: 2.153

10.  ADAM12s in maternal serum as a potential marker of pre-eclampsia.

Authors:  Kevin Spencer; Nicholas J Cowans; Anastasia Stamatopoulou
Journal:  Prenat Diagn       Date:  2008-03       Impact factor: 3.050

View more
  4 in total

1.  Pre-pregnancy or first-trimester risk scoring to identify women at high risk of preterm birth.

Authors:  Rebecca J Baer; Monica R McLemore; Nancy Adler; Scott P Oltman; Brittany D Chambers; Miriam Kuppermann; Matthew S Pantell; Elizabeth E Rogers; Kelli K Ryckman; Marina Sirota; Larry Rand; Laura L Jelliffe-Pawlowski
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-11-05       Impact factor: 2.435

2.  First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.

Authors:  Elina Keikkala; Sini Koskinen; Piia Vuorela; Hannele Laivuori; Jarkko Romppanen; Seppo Heinonen; Ulf-Håkan Stenman
Journal:  BMC Pregnancy Childbirth       Date:  2016-11-25       Impact factor: 3.007

3.  Revisiting the discriminatory accuracy of traditional risk factors in preeclampsia screening.

Authors:  Merida Rodriguez-Lopez; Philippe Wagner; Raquel Perez-Vicente; Fatima Crispi; Juan Merlo
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

4.  Systematic review of prediction models for gestational hypertension and preeclampsia.

Authors:  Edward Antwi; Mary Amoakoh-Coleman; Dorice L Vieira; Shreya Madhavaram; Kwadwo A Koram; Diederick E Grobbee; Irene A Agyepong; Kerstin Klipstein-Grobusch
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.